Caldwell & Orkin’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
AL
Caldwell & Orkin's PTEN Position: Q1 2017 in Review
Caldwell & Orkin sold out of Patterson-UTI (PTEN) in Q1 2017, closing a stake of 65,600 shares — an estimated $1.77M sold.
Caldwell & Orkin first reported a position in PTEN in Q1 2014 and held it in 5 quarters. The position peaked at $3.05M in Q2 2016. 313 funds tracked by Wall St. Rank hold PTEN as of Q1 2017.
- Caldwell & Orkin reported no remaining Patterson-UTI position as of Q1 2017 after selling out during the quarter.
- Caldwell & Orkin sold 65,600 Patterson-UTI shares in Q1 2017, an estimated $1.77M.
- Caldwell & Orkin first reported a position in Patterson-UTI in Q1 2014 and held it in 5 quarters.
- Caldwell & Orkin's Patterson-UTI position peaked at $3.05M in Q2 2016.
- 313 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2017.
Based on Caldwell & Orkin's 13F filing for Q1 2017, filed 5 May 2017.